Clinical Trial Update: A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing primary prophylaxis with Neulasta (pegfilgrastim) to secondary prophylaxis after chemotherapy in elderly cancer patients; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lung Cancer
• Neutropenia
• Non-hodgkin Lymphoma
• Ovarian Cancer

Drugs mentioned

• NEULASTA (pegfilgrastim)

Snippet

Sponsor: Amgen | Conditions: Neutropenia, Breast Cancer | Phase 4 | Status: COMPLETED